Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...
Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
(Recasts first paragraph; adds Genzyme comments, sales figures, competitors, byline; updates stock price) By Lisa Richwine GAITHERSBURG, Md., Dec 9 (Reuters) - A U.S. advisory panel has unanimously ...
To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...
WASHINGTON (Reuters) - A study of Genzyme Corp's latest version of its injectable knee pain treatment may be inadequate to weigh how well the product works, U.S. regulatory reviewers said in an ...
Genzyme has won a crucial vote by FDA advisers in favor of its single injection form of Synvisc, a therapy that eases knee pain by providing a cushion between joints. The five-member expert panel ...
Genzyme Corp. is challenging a decision by the Centers for Medicare and Medicaid Services to create a single reimbursement code for osteoarthritis treatments that would drop the reimbuirsement rate ...
Sanofi is recalling nearly 13,000 Synvisc One syringes used to treat arthritis that come from a lot that tested positive for microbial contamination. () Sanofi has initiated a U.S. recall of a lot of ...
Dr. Rob Riley joins us each week from the South Bend Clinic. Here are his responses from October 1st. George: I have rheumatoid arthritis in my knees. My doctor thinks Synvisc might help. How long ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results